Neda Shahriari
Dermatology · Boston, MANPI 1265963979
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,500 of the $2,131 with a category attached, or 70.4%. UCB, Inc. accounts for 79.8% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $1,724, more than ten times the $131 reported in 2021.
Across 11 payments — averaging $193.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- AbbVie$125
- Kyowa Kirin, Inc.$107
- Johnson & Johnson$99
- Revance Therapeutics, Inc.$28
- Sanofi$24
- plus $48 from 2 others
Across 21 payments — averaging $2041.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sun Pharmaceutical Industries Inc.$35K
- Boehringer Ingelheim International GmbH$8K
- Boehringer Ingelheim$31
What the payments were for
- Consulting fees$1,50070%
- Travel & lodging$743%
- Food & beverage$45922%
- Education$995%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 4 | $1,700 |
| AbbVie | 1 | $125 |
| Kyowa Kirin, Inc. | 1 | $107 |
| Johnson & Johnson | 1 | $99 |
| Revance Therapeutics, Inc. | 1 | $28 |
| Sanofi | 1 | $24 |
| Galderma Laboratories, L.p. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,131 in reported general payments places this provider in the 60th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammakedImmune Globul G/Gly/Iga Avg 46 | 24 | $306,096 |
| Dupixent SyringeDupilumab | 29 | $150,554 |
| Taltz AutoinjectorIxekizumab | 16 | $108,467 |
| RinvoqUpadacitinib | 17 | $106,632 |
| Cosentyx (2 Syringes)Secukinumab | 11 | $80,191 |
| Ketoconazole | 107 | $2,832 |
| Clobetasol Propionate | 24 | $2,415 |
| Metronidazole | 19 | $912 |
| Hydroxychloroquine Sulfate | 14 | $713 |
| Betamethasone Dipropionate | 12 | $574 |
| Triamcinolone Acetonide | 29 | $537 |
| Minoxidil | 27 | $167 |
| Sodium Chloride0.9 % Sodium Chloride | 11 | $127 |
| Prednisone | 21 | $125 |
| Doxycycline Monohydrate | 11 | $100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $125 | $106,63217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 552 dermatology providers in Massachusetts.
Other dermatology in Boston
- Alexandra KimballBoston$680K
- Arash MostaghimiBoston$591K
- Brian HiblerBoston$498K
- Maryanne SennaBoston$430K
- Ruth Ann VleugelsBoston$368K
- Gabriela CobosBoston$343K
- Martina PorterBoston$220K
- Mathew AvramBoston$209K
- Emmy GraberBoston$159K
- Neelam VashiBoston$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.